Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Affirms Thermo Fisher Ratings, Stable Outlook

NEW YORK (GenomeWeb) – Fitch Ratings has affirmed Thermo Fisher Scientific's ratings and its stable rating outlook.

The ratings apply to $12.5 billion of debt as of Dec. 31, 2015 and include BBB ratings for Thermo Fishers' long-term issuer default rating, senior notes, and a bank revolving credit facility; and F2 ratings for its short-term IDR and commercial paper. Fitch also affirmed a BBB rating for Thermo Fisher Subsidiary Life Technologies' long-term IDR and senior notes.

The ratings are driven by several key assumptions, including that the firm will reduce its gross debt leverage and see revenue growth between 3 percent and 4 percent over the forecast period, through the year end of 2018.

In a statement, Fitch analyst Gregory Dickerson noted that "Thermo Fisher has demonstrated solid and consistently paced improvement in credit metrics since its Life Tech acquisition, using free cash flow and proceeds from business divestitures to reduce post-acquisition debt by about $4.6 billion."

Fitch anticipates the firm will generate free cash flow of more than $3 billion, which would allow it to finance "bolt-on" acquisitions and finance share repurchases of $1 billion.

Fitch also noted that the Life Tech acquisition was "proceeding smoothly," especially since Thermo Fisher has raised its target for cost synergies, reporting $130 million of realized cost synergies in 2015, above the original 2015 synergy target of $115 million.   

Dickerson cited aggressive capital management as Thermo Fisher's key credit risk, not operating risk. Capital deployment "has occasionally contributed to higher debt levels and deterioration of credit metrics," he wrote.

Fitch upgraded Thermo Fisher's rating outlook to stable in December 2014.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.